Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) has released an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company successfully held its second extraordinary general meeting (EGM) on September 27, 2024, where all proposed resolutions were approved by shareholders through a poll. The EGM saw a robust attendance with over 55% of the total issued shares represented, and no resolutions were rejected. Additionally, the company has announced payment of an interim dividend for the first half of 2024.
For further insights into HK:0874 stock, check out TipRanks’ Stock Analysis page.
